The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an ...
The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback